150 related articles for article (PubMed ID: 36899866)
1. CRISPR/dCas9-KRAB-Mediated Suppression of
Roy Choudhury S; Heflin B; Taylor E; Koss B; Avaritt NL; Tackett AJ
Cells; 2023 Feb; 12(5):. PubMed ID: 36899866
[TBL] [Abstract][Full Text] [Related]
2. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.
Lin J; Yang Q; Yan Z; Markowitz J; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2004 Aug; 279(32):34071-7. PubMed ID: 15178678
[TBL] [Abstract][Full Text] [Related]
4. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis.
Scotto C; Deloulme JC; Rousseau D; Chambaz E; Baudier J
Mol Cell Biol; 1998 Jul; 18(7):4272-81. PubMed ID: 9632811
[TBL] [Abstract][Full Text] [Related]
5. Covalent small molecule inhibitors of Ca(2+)-bound S100B.
Cavalier MC; Pierce AD; Wilder PT; Alasady MJ; Hartman KG; Neau DB; Foley TL; Jadhav A; Maloney DJ; Simeonov A; Toth EA; Weber DJ
Biochemistry; 2014 Oct; 53(42):6628-40. PubMed ID: 25268459
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
7. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
8. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
9. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription.
Kawauchi J; Zhang C; Nobori K; Hashimoto Y; Adachi MT; Noda A; Sunamori M; Kitajima S
J Biol Chem; 2002 Oct; 277(41):39025-34. PubMed ID: 12161427
[TBL] [Abstract][Full Text] [Related]
11. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK.
Hartman KG; Vitolo MI; Pierce AD; Fox JM; Shapiro P; Martin SS; Wilder PT; Weber DJ
J Biol Chem; 2014 May; 289(18):12886-95. PubMed ID: 24627490
[TBL] [Abstract][Full Text] [Related]
12. The evolution of S100B inhibitors for the treatment of malignant melanoma.
Hartman KG; McKnight LE; Liriano MA; Weber DJ
Future Med Chem; 2013 Jan; 5(1):97-109. PubMed ID: 23256816
[TBL] [Abstract][Full Text] [Related]
13. Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation.
Chowdhury R; Chowdhury S; Roychoudhury P; Mandal C; Chaudhuri K
Apoptosis; 2009 Jan; 14(1):108-23. PubMed ID: 19082730
[TBL] [Abstract][Full Text] [Related]
14. PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo.
Bao W; Chen M; Zhao X; Kumar R; Spinnler C; Thullberg M; Issaeva N; Selivanova G; Strömblad S
Cell Cycle; 2011 Jan; 10(2):301-7. PubMed ID: 21239882
[TBL] [Abstract][Full Text] [Related]
15. Serum S100B Levels in Melanoma.
Frauchiger AL; Dummer R; Mangana J
Methods Mol Biol; 2019; 1929():691-700. PubMed ID: 30710305
[TBL] [Abstract][Full Text] [Related]
16. S100B expression in breast cancer as a predictive marker for cancer metastasis.
Yen MC; Huang YC; Kan JY; Kuo PL; Hou MF; Hsu YL
Int J Oncol; 2018 Feb; 52(2):433-440. PubMed ID: 29345293
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein.
Lin J; Blake M; Tang C; Zimmer D; Rustandi RR; Weber DJ; Carrier F
J Biol Chem; 2001 Sep; 276(37):35037-41. PubMed ID: 11454863
[TBL] [Abstract][Full Text] [Related]
18. Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells.
Liu B; Song J; Han H; Hu Z; Chen N; Cui J; Matsubara JA; Zhong J; Lei H
Lab Invest; 2019 Dec; 99(12):1874-1886. PubMed ID: 31439892
[TBL] [Abstract][Full Text] [Related]
19. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide.
Strasberg Rieber M; Zangemeister-Wittke U; Rieber M
Clin Cancer Res; 2001 May; 7(5):1446-51. PubMed ID: 11350916
[TBL] [Abstract][Full Text] [Related]
20. Design of Inhibitors for S100B.
Markowitz J; Mackerell AD; Carrier F; Charpentier TH; Weber DJ
Curr Top Med Chem; 2005; 5(12):1093-108. PubMed ID: 16248785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
